$VREX

Varex Returns To Profit In Q3 On Absence Of One-time Impairment Charge, Shares Up By 48%

Varex Imaging Corp. (VREX) reported Q3 2026 profit of $15.7M, or $0.37/share, versus a $89.1M loss, or $2.15/share, a year earlier, helped by lower expenses and the absence of a $93.9M goodwill impairment. Revenue rose to $210.5M from $203.0M. Shares rose about 48.7% premarket to $18.45.

Original reporting
Published Aug 10, 2026, 6:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 6:43 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Varex Returns To Profit In Q3 On Absence Of One-time Impairment Charge, Shares Up By 48% — source image
Decision brief

The 30-second read

$VREXBullishMed
01

Why it matters

Lower operating expenses (including no goodwill impairment) drove the profit turnaround, with adjusted metrics also improving versus the prior year.

02

Market read

The market is reacting to a cleaner earnings profile and improved adjusted profitability, with shares sharply higher in pre-market trading.

03

What to watch

The article does not break out revenue drivers or segment performance, so traders may be over-weighting the absence of impairment versus operational momentum.

Relevance 8/10Novelty 6/10Timing: pre-market today after Q3 results

Background

Varex Imaging reported a return to profitability in Q3 2026 after a loss in the prior-year quarter that included a large goodwill impairment.

Company-level read

Ticker impact

$VREXBullishMedium confidence
Context

Varex reported Q3 2026 profit of $15.7M ($0.37/share) versus a prior-year loss, citing lower expenses and no goodwill impairment this year.

Expected impact

Shares were up about 48.7% pre-market, suggesting the market is rewarding the cleaner expense profile and profit return.

Evidence & confidence

The article provides directionally strong financials (profit, lower operating expenses, higher adjusted EBITDA) and a clear bridge versus last year’s impairment, which is typically a key driver of earnings quality and multiple expansion.

Market effects

Improves sentiment for X-ray imaging components suppliers by highlighting earnings leverage when impairment charges do not recur.

No specific regional spillover mentioned beyond Nasdaq pre-market reaction.

No explicit global demand or regulatory developments cited.

Counterpoint

Profit improvement may be partly mechanical versus last year’s impairment; without details on underlying demand, the sustainability of margins could be questioned.

Key entities

  • Varex Imaging Corp.

    X-ray imaging components provider reporting Q3 2026 profit and improved adjusted profitability.

Related articles

$HZOHighAI 9/10

MarineMax Leaps 46.1% After Announcing Deal

MarineMax shares rose 46.1% after the company agreed to be sold for about $1.5 billion in cash to a Blackstone portfolio company. Varex Imaging jumped 48.8% after Teledyne Technologies said it will buy it for $18.90 per share. The S&P 500, Dow, and Nasdaq fell slightly as Brent crude rose to $87.72.

$TDYHighAI 9/10

Teledyne to acquire Varex Imaging for $1.1 billion | MLex | Specialist news and analysis on legal risk and regulation

Teledyne Technologies agreed to acquire Varex Imaging for $18.90 per share in cash, valuing the deal at about $1.1 billion including Varex equity awards and net debt, according to an official statement. The merger combines Teledyne’s digital imaging, instrumentation, and aerospace and defense electronics with Varex’s X-ray imaging components.

$TDYHighAI 10/10

$18.90 a Share, 48% Higher: Teledyne’s $1.1 Billion Bet on X

Teledyne Technologies agreed to acquire Varex Imaging for about $1.1 billion, paying $18.90 cash per Varex share. Varex shares rose nearly 48% to around $18.42 on Monday. The boards approved unanimously; deal needs regulatory approvals and Varex shareholder vote, with expected close in early 2027.

$TDYHighAI 9/10

Teledyne Technologies Acquires Varex Imaging in $1.1 Billion Deal

Teledyne Technologies agreed to buy Varex Imaging in an all-cash deal valued at about $1.1 billion. Teledyne will pay $18.90 per Varex share. Boards approved; closing is expected in early 2027, pending regulatory clearance and Varex shareholder approval. The acquisition targets expanded advanced X-ray imaging capabilities for medical and industrial markets.

$TDYHighAI 9/10

Teledyne To Buy Varex Imaging For About $1.1 Bln In Cash

Teledyne Technologies (TDY) agreed to buy Varex Imaging (VREX) for $18.90 per share in cash, valuing the deal at about $1.1 billion including debt and equity awards as of April 3, 2026, according to the companies. Both boards unanimously approved. The deal is expected to close in early 2027. VREX shares jumped in pre-market.